Open Access · CC BY 4.0
Back to the basics: How the preclinical rationale shapes the immunotherapy landscape for hepatocellular carcinoma
Liver Cancer International · 2021
DOI: 10.1002/lci2.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer International, 2021. Verfasst von Antonio D’Alessio und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
D’Alessio, A., & Rimassa, L. (2021). Back to the basics: How the preclinical rationale shapes the immunotherapy landscape for hepatocellular carcinoma. Liver Cancer International. https://doi.org/10.1002/lci2.24
Vancouver
D’Alessio A, Rimassa L. Back to the basics: How the preclinical rationale shapes the immunotherapy landscape for hepatocellular carcinoma. Liver Cancer International. 2021. doi:10.1002/lci2.24
BibTeX
@article{DAlessio2021,
author = {D’Alessio, Antonio and Rimassa, Lorenza},
title = {Back to the basics: How the preclinical rationale shapes the immunotherapy landscape for hepatocellular carcinoma},
journal = {Liver Cancer International},
year = {2021},
doi = {10.1002/lci2.24}
}
EUVIMED